Abstract
The disposition kinetics and dosage regimen of enrofloxacin were investigated in breeding buffalo bulls following a single intramuscular administration of 5 mg/kg. The absorption half-life, half-life of the terminal phase, apparent volume of distribution and total body clearance were 0.262±0.099 h, 1.97±0.23 h, 0.61±0.13 L/kg and 210.2±18.6 ml/(kg.h), respectively. Therapeutic plasma levels (≥1 μg/ml) were maintained for up to 6 h. A satisfactory intramuscular dosage regimen for enrofloxacin in buffalo bulls would be 8.5 mg/kg followed by 8.0 mg/kg at 8 h intervals.
Similar content being viewed by others
REFERENCES
Ahangar, A.A., 1998. Effect of fever on pharmacokinetics and dosage regimen of enrofloxacin in cow calves, (MVSc thesis, Punjab Agricultural University, Ludhiana, India)
Altreuther, P., 1987. Data on chemistry and toxicology of Baytril. Veterinary Medicine Review, 2, 87—89
Arret, B., Johnson, D.P. and Krishbaum, A., 1971. Outline of details for microbiological assay of antibiotics: Second Revision. Journal of Pharmaceutical Science, 60, 1689—1694
Baggot, J.D., 1977. Principles of drug disposition in domestic animals. In: J.D. Baggot (ed.), The Basis of Veterinary Clinical Pharmacology, (W.B. Saunders, Philadelphia), 144—189
Bauditz, R., 1990. Enrofloxacin — clinical evaluation in several animals. In: F. Siman, P. Lees and G. Semjen (eds),Veterinary Pharmacology, Toxicology and Therapy in Food Producing Animals, (University of Veterinary Science, Unipharma Co. Ltd, Budapest), 21—26
Cabanes, A., Arboix, M., Gracia, J.M. and Reign, F., 1992. Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. American Journal of Veterinary Research, 53, 2090—2093
Dowling, P.M., Wilson, R.C., Tyler, J.W. and Duran, S.H., 1995. Pharmacokinetics of ciprofloxacin in ponies. Journal of Veterinary Pharmacology and Therapeutics, 18, 7—12
Gandorfer, B., 1991. Pharmacokinetics of Baytril (enrofloxacin), particularly passage from blood to milk, (Inaugural dissertation, Tierarztliche Fakultat, Ludwig Maximilians-Universität, Munchen), 104
Gatne, M.M. and Ranade,V.V., 1996. Enrofloxacin — a new drug. The Blue Cross Book, 6, 26—28
Gibaldi, M. and Perrier, D., 1982. Appendix C: Method of residuals. Pharmacokinetics, (Marcel Dekker, New York), 433—444
Kuhn, H., 1993. Pharmacokinetic studies on the gyrase inhibitors enrofloxacin and ofloxacin, (Inaugural dissertation, Tierarztliche Fakultat, Ludwig Maximilians-Universität, Munchen), 214
Kung, K., Riond, J.L. and Wanner, M., 1993. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 16, 462—468
Prescott, J.F. and Yielding, K.M., 1990. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Canadian Journal of Veterinary Research, 54, 195—197
Scheer, M., 1987. Studies on the antimicrobial activity of Baytril. Veterinary Medicine Review, 2, 90—99
Steeve, G., Raymond,W.S. and Myriam, B., 1996. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses. American Journal of Veterinary Research, 7, 1025—1030
Vancutsem, M., Babish, J.G. and Schwark, W.S., 1990. The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Veterinarian, 80, 173—186
Zehe, V., 1990. Pharmacokinetics of DNA gyrase inhibitor enrofloxacin in horses, (Inaugural dissertation, Tierarztliche Hochschule, Hannover; CAB Abstract 060–05812)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Verma, H., Pangawkar, G., Chaudhary, R. et al. Pharmacokinetics and Dosage Regimen of Enrofloxacin in Buffalo Bulls after Intramuscular Administration. Vet Res Commun 23, 501–505 (1999). https://doi.org/10.1023/A:1006366507016
Issue Date:
DOI: https://doi.org/10.1023/A:1006366507016